Accelerate Diagnostics (AXDX)
(Delayed Data from NSDQ)
$1.78 USD
+0.06 (3.49%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.75 -0.03 (-1.69%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for Accelerate Diagnostics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -61.62 | -62.49 | -77.70 | -78.21 | -84.31 |
Depreciation/Amortization & Depletion | 7.57 | 4.41 | 14.29 | 14.26 | 12.14 |
Net Change from Assets/Liabilities | 4.97 | 2.25 | -0.10 | -3.35 | -6.09 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 8.89 | 7.11 | 16.20 | 16.90 | 13.46 |
Net Cash From Operating Activities | -40.20 | -48.73 | -47.32 | -50.39 | -64.79 |
Property & Equipment | -1.04 | -0.55 | -0.60 | -1.36 | -0.33 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 9.70 | 12.97 | 8.91 | 14.97 | 53.14 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 8.66 | 12.42 | 8.30 | 13.61 | 52.81 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 14.00 | 33.10 | 44.83 | 6.06 | 6.82 |
Issuance (Repayment) of Debt | 0.00 | -0.08 | -0.36 | 5.21 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -4.98 | -1.39 | -1.24 | 0.36 | 0.00 |
Net Cash from Financing Activities | 9.02 | 31.63 | 43.23 | 11.63 | 6.82 |
Effect of Exchange Rate Changes | -0.25 | -0.31 | -0.09 | -0.08 | -0.09 |
Net Change In Cash & Equivalents | -22.77 | -4.99 | 4.12 | -25.23 | -5.25 |
Cash at Beginning of Period | 34.91 | 39.90 | 35.78 | 61.01 | 66.26 |
Cash at End of Period | 12.14 | 34.91 | 39.90 | 35.78 | 61.01 |
Diluted Net EPS | -4.94 | -7.60 | -12.60 | -14.00 | -15.50 |
Fiscal Year End for Accelerate Diagnostics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -25.82 | -14.23 | -61.62 | -48.62 | -49.53 |
Depreciation/Amortization & Depletion | 5.05 | 2.45 | 7.57 | 5.53 | 3.34 |
Net Change from Assets/Liabilities | -1.47 | 0.11 | 4.97 | 5.14 | 1.48 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.21 | 3.22 | 8.89 | 5.51 | 20.52 |
Net Cash From Operating Activities | -16.04 | -8.45 | -40.20 | -32.44 | -24.19 |
Property & Equipment | -0.52 | -0.51 | -1.04 | -0.93 | -0.17 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 9.70 | 9.70 | 9.29 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.52 | -0.51 | 8.66 | 8.77 | 9.12 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 14.00 | 14.00 | 4.00 |
Issuance (Repayment) of Debt | -0.73 | 0.00 | 0.00 | 0.00 | 10.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 13.56 | 11.44 | -4.98 | -5.09 | -4.27 |
Net Cash from Financing Activities | 12.84 | 11.44 | 9.02 | 8.91 | 9.73 |
Effect of Exchange Rate Changes | 0.17 | -0.01 | -0.25 | 0.02 | -0.29 |
Net Change In Cash & Equivalents | -3.55 | 2.47 | -22.77 | -14.74 | -5.62 |
Cash at Beginning of Period | 12.14 | 12.14 | 34.91 | 34.91 | 34.91 |
Cash at End of Period | 8.59 | 14.61 | 12.14 | 20.16 | 29.28 |
Diluted Net EPS | -0.50 | -0.74 | -0.33 | 0.06 | -2.97 |